GlobalSpace Technologies Launches PATGPT, a Pharma-Specific LLM Platform

GlobalSpace Technologies Ltd has announced the launch of PATGPT, a Pharma-specific Large Language Model (LLM) platform. The platform operates under a hybrid model, combining GlobalSpace's pre-trained pharmaceutical datasets with proprietary datasets of pharmaceutical companies. This dual approach allows pharma companies to securely build organization-specific AI intelligence. Initially, PATGPT will focus on sales, marketing, inventory, and distribution optimization, with future plans to expand into R&D, clinical trials, pharmacovigilance, and regulatory submissions. GlobalSpace Technologies, a listed digital solutions company, is focused on the healthcare and pharmaceutical sectors, providing SaaS platforms and AI-powered solutions.